ATELLICA TM CH APOLIPOPROTEÍNA A‑1 / B
Mexico·Clase I·III. DIAGNOSTIC AGENTS·SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.·Registered August 03, 2018EL ENSAYO ATELLICA™ CH APOLIPOPROTEIN A‑1 (APO A1) ES PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE APOLIPOPROTEÍNA A‑1 EN SUERO Y PLASMA (HEPARINA DE LITIO) HUMANOS. EL ENSAYO ATELLICA™ CH APOLIPOPROTEIN B (APO B) ES PARA
THE ATELLICA™ CH APOLIPOPROTEIN A-1 (APO A1) ASSAY IS FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE DETERMINATION OF APOLIPOPROTEIN A-1 IN HUMAN SERUM AND PLASMA (LITHIUM HEPARIN). THE ATELLICA™ CH APOLIPOPROTEIN B (APO B) ASSAY IS FOR
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN DE APOLIPOPROTEÍNAS
- Trade Name (English)
- REAGENT FOR THE DETERMINATION OF APOLIPOPROTEINS
- Analysis ID
- 1872R2018 SSA
- Registration Date
- August 03, 2018
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
Access comprehensive regulatory information for ATELLICA TM CH APOLIPOPROTEÍNA A‑1 / B (ATELLICA TM CH APOLIPOPROTEÍNA A‑1 / B) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1872R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on August 03, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.